We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

BY Editorial Team |May 28 2021

Laboratory scientists across the globe are invited to vote for their favorite clinical products of 2020. Here’s how.

We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

The 2021 Scientists Choice Awards®

SelectScience’s annual Scientists' Choice Awards is celebrating its 14th anniversary by honoring the most innovative and effective technologies of the past year. The awards provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to their work.

Thanks to our loyal customers, we’re delighted to announce the Access SARS-CoV-2 IgM assay > has been nominated in the Best New Clinical Assay/Kit of 2020 category.

Our high-sensitivity and high-specificity SARS-CoV-2 IgM assay > has market-leading accuracy with a high positive predictive value (PPV) and a high negative predictive value (NPV). This provides clinicians with useful immune response information and may help determine if their patients have had a recent COVID-19 infection.

Casting Your Vote

Voting closes Sunday, June 13, 2021. All scientists who cast their vote for their favorite clinical products of 2020 will be entered into a drawing for a chance to win a $500/£400/450 € Amazon Gift Card from SelectScience.

Interested in sharing your thoughts?

Vote now

Editorial Team

The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

See all by Editorial Team

Viral Hepatitis: Why Accurate Diagnosis Is Key to Global Health

BY Editorial Team |December 16 2025

5 min read

Insights from ADLM Webinar Featuring Prof. Stéphane Chevaliez. Viral hepatitis—especially hepatitis B (HBV) and hepatitis C (HCV)—continues to pose a major global health threat and remains one of the most pressing global health challenges.

The Hidden Cost of Misdiagnosis

BY Beckman Coulter |December 12 2025

5 min read

Urinary tract infections (UTIs) account for approximately 10 million healthcare visits annually in the United States, making them one of the most common infections clinicians encounter.

From Core to Lab to Community: Delivering High-Quality HIV Testing Across Rural Wisconsin

BY Editorial Team |November 28 2025

4 min read

Explore how Marshfield Clinic Health System's adoption of the Access HIV Ag/Ab combo assay on the DxI 9000 Access Immunoassay Analyzer is expanding access to high-performance HIV diagnostics across rural Wisconsin.

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

All trademarks used herein are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language

Country or Region

Language